Association between Pain Severity and Health Care Resource Use, Health Status, Productivity and Related Costs in Painful Diabetic Peripheral Neuropathy Patients

被引:28
|
作者
DiBonaventura, Marco daCosta [1 ]
Cappelleri, Joseph C. [2 ]
Joshi, Ashish V. [3 ]
机构
[1] Kantar Hlth, Hlth Sci Practice, New York, NY 10010 USA
[2] Pfizer Inc, Global Res & Dev, New London, CT USA
[3] Pfizer Inc, Hlth Econ & Outcomes Res, New York, NY USA
关键词
Painful Diabetic Peripheral Neuropathy; Pain Severity; Quality of Life; Work Productivity and Activity Impairment; Resource Use; QUALITY-OF-LIFE; ACTIVITY IMPAIRMENT; WORK PRODUCTIVITY; EUROPEAN-UNION; IMPACT; PREVALENCE; EPIDEMIOLOGY; VALIDITY;
D O I
10.1111/j.1526-4637.2011.01103.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objective. Research has shown that painful diabetic peripheral neuropathy (pDPN) is associated with worse health outcomes. However, among pDPN patients, few studies have examined the relationship between the severity of pain and health outcomes. Design. The current project included pDPN patients (N = 1,506) from the 2006, 2007, and 2008 waves of the National Health and Wellness Survey. Outcome Measures. Health status (Short Form [SF]-12), work productivity (Work Productivity and Activity Impairment questionnaire), and health care resource use in the past 6 months were compared among pDPN patients with mild, moderate, and severe pain, adjusting for demographics and clinical characteristics. Results. More than half (51.2%) of the patients reported their pain as severe, 45.2% reported moderate pain, and 3.7% reported mild pain. Those with severe pain reported significantly lower levels of health status, higher levels of work and activity impairment, and higher levels of resource use relative to the other groups. Annual per-patient costs for those with severe pain were $12,856, $3,927, and $16,783 for direct, indirect, and total costs, respectively. Both direct and total costs were significantly higher in this group relative to both mild and moderate pain patients. Conclusions. These results suggest that pain severity contributes substantially to the health outcomes of pDPN patients and that greater resources should be allocated to the management of patients with severe pain.
引用
收藏
页码:799 / 807
页数:9
相关论文
共 50 条
  • [1] A Longitudinal Assessment of Painful Diabetic Peripheral Neuropathy on Health Status, Productivity, and Health Care Utilization and Cost
    DiBonaventura, Marco daCosta
    Cappelleri, Joseph C.
    Joshi, Ashish V.
    [J]. PAIN MEDICINE, 2011, 12 (01) : 118 - 126
  • [2] Health Care Costs in Patients with Painful Diabetic Peripheral Neuropathy Prescribed Pregabalin or Duloxetine
    Burke, James P.
    Sanchez, Robert J.
    Joshi, Ashish V.
    Cappelleri, Joseph C.
    Kulakodlu, Mahesh
    Halpern, Rachel
    [J]. PAIN PRACTICE, 2012, 12 (03) : 209 - 218
  • [3] Pain severity affects perceived health status in patients with diabetic peripheral neuropathy
    Gore, M
    Brandenburg, N
    Hoffman, D
    Tai, KS
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 344 - 344
  • [4] Impact of Postherpetic Neuralgia and Painful Diabetic Peripheral Neuropathy on Health Care Costs
    Dworkin, Robert H.
    Malone, Daniel C.
    Panarites, Christopher J.
    Armstrong, Edward P.
    Pham, Sissi V.
    [J]. JOURNAL OF PAIN, 2010, 11 (04): : 360 - 368
  • [5] The association between lower back pain and health status, work productivity, and health care resource use in Japan
    Sadosky, Alesia B.
    DiBonaventura, Marco
    Cappelleri, Joseph C.
    Ebata, Nozomi
    Fujii, Koichi
    [J]. JOURNAL OF PAIN RESEARCH, 2015, 8 : 119 - 130
  • [6] How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?
    Hoffman, Deborah L.
    Sadosky, Alesia
    Dukes, Ellen M.
    Alvir, Jose
    [J]. PAIN, 2010, 149 (02) : 194 - 201
  • [7] Painful diabetic peripheral neuropathy Health care costs and complications from 2010 to 2015
    Kiyani, Musa
    Yang, Zidanyue
    Charalambous, Lefko T.
    Adil, Syed M.
    Lee, Hui-Jie
    Yang, Siyun
    Pagadala, Promila
    Parente, Beth
    Spratt, Susan E.
    Lad, Shivanand P.
    [J]. NEUROLOGY-CLINICAL PRACTICE, 2020, 10 (01) : 47 - 57
  • [8] The health care costs of diabetic peripheral neuropathy in the US
    Gordois, A
    Scuffham, P
    Shearer, A
    Oglesby, A
    Tobian, JA
    [J]. DIABETES CARE, 2003, 26 (06) : 1790 - 1795
  • [9] The health care costs of diabetic peripheral neuropathy in the United States
    Gordois, A
    Scuffham, P
    Shearer, A
    Oglesby, A
    [J]. DIABETES, 2003, 52 : A193 - A193
  • [10] Vow do changes in average pain severity levels among patients with painful diabetic peripheral neuropathy correspond to changes in health status and functional outcomes?
    Hoffman, D. L.
    Sadosky, A.
    Alvir, J. Ma J.
    Dukes, E. M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 170 - 170